Clinical Trials Logo

Pediatric ALL clinical trials

View clinical trials related to Pediatric ALL.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06303687 Enrolling by invitation - Acute Pain Clinical Trials

VR-PAT and fNIRS to Identify CNS Biomarkers of Pain

Start date: July 2024
Phase: N/A
Study type: Interventional

This study aims to use functional near-infrared spectroscopy (fNIRS) to identify and quantify pain biomarkers during burn dressing changes and pain relief induced by virtual reality (VR).

NCT ID: NCT05962905 Enrolling by invitation - Pediatric ALL Clinical Trials

Accuracy Performance Verification of the INVOS™ System in Pediatrics

INCATH
Start date: November 16, 2023
Phase:
Study type: Observational

Prospective, observational, multi-center trial designed to capture calibration and performance evaluation data with the INVOS™ system.

NCT ID: NCT05818644 Enrolling by invitation - Pediatric ALL Clinical Trials

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

HEPATIC
Start date: September 28, 2023
Phase:
Study type: Observational

The goal of this observational study is to investigate the incidence, current management practices, and outcomes in pediatric patients with HAC after liver transplantation. Research question: - What are the overall incidence of HAC and the effectiveness of all treatment strategies for HAC after pediatric LT? - What are the current management practices in the experience of centers, anticoagulant therapy, screening protocol, and assessment criteria for HAC after pediatric LT? The burden of participation is considered to be minimal, and limited to the questionnaires.

NCT ID: NCT05686590 Enrolling by invitation - Hypoglycemia Clinical Trials

Prehospital Provider Training With Augmented Reality (AR)

Start date: December 12, 2022
Phase: N/A
Study type: Interventional

The goal is to evaluate the acceptance of Augmented Reality (AR) simulation as a learning modality for prehospital providers. The simulation itself is grounded in traditional best practices for simulation delivery and design as well as prior literature on simulation training for prehospital providers; the focus of this study is the participants' experiential interaction with AR and the simulation resources.

NCT ID: NCT05673551 Enrolling by invitation - Acute Pain Clinical Trials

VR-PAT During Home Burn Dressings - Multisite

Start date: January 16, 2023
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of smartphone Virtual Reality Pain Alleviation Therapy (VR-PAT) as a pain distraction tool during repeated at-home burn dressing changes among 100 children (age 6-17 years) with a burn injury in comparison to 100 children with a burn injury who do not use the VR-PAT.

NCT ID: NCT04936776 Enrolling by invitation - Pediatric ALL Clinical Trials

Pediatric Vaccinations

Start date: February 9, 2021
Phase:
Study type: Observational

As the Covid-19 pandemic hit New York City in the spring of 2020, many families were home-bound due to the city-wide lockdown. As a result, families in New York City were unable to attend their child's healthcare appointments and many young children did not receive their regularly-scheduled vaccinations. Parts of the city-wide lockdown did eventually lift in the summer of 2020 as positive Covid-19 virus rates declined in NYC. However, regularly scheduled vaccination rates (non-Covid-related) remain low. Yet, it is critical that young children receive their mandatory vaccines in a timely manner to decrease the chance of contracting preventable illnesses. Thus, the investigators seek to increase vaccination rates among children ages 0-2 years in Sunset Park Brooklyn.

NCT ID: NCT04735211 Enrolling by invitation - Pediatric ALL Clinical Trials

Chronic Postsurgical Pediatric Pain. Evaluation Risk Factors to Develop Chronic Postsurgical Pain in Children and Adolescents Undergoing Surgery in a First Level Hospital

Start date: December 15, 2020
Phase:
Study type: Observational

Chronic postsurgical pain had number of prevalence on 20%. Its derivates from risk factors, but recent research provide new potential risk factors to develop chronic postsurgical pediatric pain. To increase the body of knowledge, an observational study is proposed in pediatric patients undergoing surgical intervention.

NCT ID: NCT04670731 Enrolling by invitation - Pediatric ALL Clinical Trials

Ventricular Remodelling and Metabolomics in Pediatric Cardiomyopathies (PROGRESS-OMICS)

PRO-OMICS
Start date: February 2021
Phase:
Study type: Observational

The pathogenesis of cardiomyopathies is complex and a simple approach cannot describe the whole picture. Different etiologies are reported in pediatric age and heart failure onset can lead to poor prognosis in term of need of heart transplantation and ventricular assist device implantation. Based on hypothesis that heart failure development is related to heart inability to meet metabolic demands of the body, our study will focus to evaluate cardiac metabolism as one of the most critical factors and the accompanying changes of metabolic and echocardiographic profiles at different stages of heart failure. The heart is a unique organ working continuously as a pump supplying blood to the body. To meet this requirement, the myocardium utilizes fatty acids to generate 70-90% of the adenosine triphospate, with the rest being produced by oxidation of glucose, lactate, ketone bodies, aminoacids. Utilization of fatty acids is reduced in the failing heart and there is a metabolic shift to generation of adenosine triphospate from glucose. In patients with advanced cardiomyopathies, the heart is unable to utilize either metabolite and thus "runs out of fuel". It is reported that the adenosine triphospate level is approximately 30% lower in failing human hearts compared with non-failing hearts. In addition to this premise about the metabolic profile of the failing heart, recent advances in the field of metabolomics have indicated that several metabolites and/or metabolic pathways have a role in heart failure. Metabolism of lipids, glycolysis, fructolysis, aminoacids, and ketone oxidation have been found to be altered in non-ischemic cardiomyopathy in adult population. Also in adult heart failure patients some metabolic profiles resulted pronounced perturbated. Taking advantage of the high throughput, metabolomics is a platform for identifying metabolic signatures in children at each stages of heart failure (from pre clinical heart failure to end stage forms). We also will determine whether metabolomic analysis provides sensitive evaluation of heart failure in terms of remodelling at different stages and in disease regression after therapeutic interventions. Study desing is conceived in two parts. The first part is retrospective and we will analyze all echocardiograms in all children affected by cardiomyopathies. The second part is a cross sectional study in which will evaluate untargeted metabolomics in children at any stage of heart failure (A,B, C, D) and in control group. We will evaluate the clinical applicability and significance of plasma metabolomic analysis in the diagnosis and prognosis of heart failure in pediatric ages.